Stock Scorecard
Stock Summary for U.S. Physical Therapy Inc (USPH) - $100.38 as of 4/26/2024 3:54:19 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for USPH
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for USPH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for USPH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for USPH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for USPH
Financial Details for USPH
Company Overview |
|
|---|---|
| Ticker | USPH |
| Company Name | U.S. Physical Therapy Inc |
| Country | USA |
| Description | US Physical Therapy, Inc. operates outpatient physical therapy clinics that provide preoperative and postoperative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, injured worker rehabilitation, and neurology-related injuries. The company is headquartered in Houston, Texas. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-HEALTH SERVICES |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/8/2024 |
Stock Price History |
|
| Last Day Price | 100.38 |
| Last Day Price Updated | 4/26/2024 3:54:19 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 72,157 |
| 52-Week High | 122.46 |
| 52-Week Low | 77.37 |
| Last Price to 52 Week Low | 29.74% |
Valuation Measures |
|
| Trailing PE | 78.60 |
| Industry PE | 73.50 |
| Sector PE | 56.64 |
| 5-Year Average PE | 26.90 |
| Free Cash Flow Ratio | 9.90 |
| Industry Free Cash Flow Ratio | 38.98 |
| Sector Free Cash Flow Ratio | 30.65 |
| Current Ratio Most Recent Quarter | 2.28 |
| Total Cash Per Share | 10.14 |
| Book Value Per Share Most Recent Quarter | 31.77 |
| Price to Book Ratio | 3.25 |
| Industry Price to Book Ratio | 3.83 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 2.59 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.68 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
| Total Shares Outstanding | 15,068,100 |
| Market Capitalization | 1,512,535,878 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/11/2024 |
| Last Dividend Amount | 0.43 |
| Current Dividend Amount | 0.44 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 1.73 |
| Trailing Annual Dividend Yield | 1.72% |
| Forward Annual Dividend Rate | 1.92 |
| Forward Annual Dividend Yield | 1.91% |
| 5-Year Dividend Payments Count | 17 |
| 3-Year Average Dividend Yield | 1.80% |
| 5-Year Average Dividend Yield | 1.33% |
| 1-Year Dividend Growth Rate Percentage | 4.88% |
| 3-Year Dividend Growth Rate Percentage | 8.54% |
| 5-Year Dividend Growth Rate Percentage | 10.83% |
| All-Time Dividend Growth Rate Percentage | 15.04% |
| Dividend Payout Ratio | 136.22% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -30.10% |
| Annual Earnings Growth | -12.19% |
| Reported EPS 12 Trailing Months | 1.28 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 2.56 |
| Net Income Twelve Trailing Months | 28,239,000 |
| Net Income Past Year | 28,239,000 |
| Net Income Prior Year | 32,158,000 |
| Quarterly Revenue Growth YOY | 9.60% |
| 5-Year Revenue Growth | 5.91% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 152,825,000 |
| Total Cash Past Year | 152,825,000 |
| Total Cash Prior Year | 31,594,000 |
| Net Cash Position Most Recent Quarter | 15,302,000 |
| Net Cash Position Past Year | 15,302,000 |
| Long Term Debt Past Year | 137,523,000 |
| Long Term Debt Prior Year | 173,970,000 |
| Total Debt Most Recent Quarter | 137,523,000 |
| Equity to Debt Ratio Past Year | 0.78 |
| Equity to Debt Ratio Most Recent Quarter | 0.78 |
| Total Stockholder Equity Past Year | 476,194,000 |
| Total Stockholder Equity Prior Year | 315,793,000 |
| Total Stockholder Equity Most Recent Quarter | 476,194,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.38 |
| MACD Signal | -1.02 |
| 20-Day Bollinger Lower Band | 86.32 |
| 20-Day Bollinger Middle Band | 99.44 |
| 20-Day Bollinger Upper Band | 112.55 |
| Beta | 1.38 |
| RSI | 48.56 |
| 50-Day SMA | 99.97 |
| 200-Day SMA | 98.28 |
System |
|
| Modified | 4/27/2024 1:51:38 PM EST |